Company intelligence / Profile preview
Shanghai ForeFront Pharmaceutical
Shanghai, Shanghai, Chinaforefrontpharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Shanghai ForeFront Pharmaceutical is an R&D-driven biopharmaceutical company specializing in high-end generics and innovative drugs, particularly for oncology, anti-inflammation, antiviral, and orphan diseases. Their portfolio includes difficult-to-synthesize molecules, semisynthetic drugs, and advanced formulations (CR & SR, fixed dose combinations), with a focus on preclinical R&D programs aiming for global filings in China, US, and EU. No clinical outcomes have been publicly disclosed as of late 2024.
- Therapeutic areas
- ImmunologyInfectious DiseasesRare DiseasesCardiovascularOncologyNeurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Shanghai ForeFront Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai ForeFront Pharmaceutical.